Private Placement Warrants
DCRB’s Sponsor, certain of DCRB’s independent
directors consisting of Dr. Jennifer Aaker, Jane Kearns, Jim
McDermott, Jeffrey Tepper and Michael Warren and WRG purchased an
aggregate of 6,000,000 private placement warrants for a purchase
price of $1.00 per warrant in a private placement that occurred
simultaneously with the closing of DCRB’s initial public offering.
On November 12, 2020, DCRB completed a private placement with
its Sponsor and WRG for an additional 514,500 warrants at a price
of $1.00 per warrant, generating gross proceeds of approximately
$514,500. As such, the interest of DCRB’s Sponsor, certain of
DCRB’s independent directors and WRG in this transaction is valued
at approximately $6,514,500.
In connection with the Closing, an additional
1,500,000 private placement warrants were also issued to the DCRB
Sponsor, see Related Party Loans and Advances,
below.
Each private placement warrant entitles the
holder to purchase one share of our Class A Common Stock at
$11.50 per share.
Administrative Support
Agreement
On October 19, 2020, DCRB entered into
an administrative support agreement with an affiliate of its
Sponsor, pursuant to which DCRB paid an affiliate of its Sponsor a
total of $10,000 per month for office space, utilities and
secretarial and administrative support. Upon consummation of the
Business Combination, DCRB ceased paying these monthly
fees.
DCRB’s Sponsor, officers and directors, or
any of their respective affiliates, have been reimbursed for any
out-of-pocket expenses incurred
in connection with activities on DCRB’s behalf. There was no cap or
ceiling on the reimbursement of out-of-pocket expenses incurred
by such persons in connection with activities on DCRB’s
behalf.
Related Party Loans and
Advances
DCRB’s liquidity needs up to its initial
public offering were satisfied through receipt of a $25,000 capital
contribution from DCRB’s Sponsor in exchange for the issuance of
DCRB Founder Shares to DCRB’s Sponsor and a loan from DCRB’s
Sponsor for an aggregate amount of $300,000 to cover organizational
expenses and expenses related to the initial public offering
pursuant to a promissory note. On September 13, 2017, DCRB
drew down $300,000 on this promissory note. DCRB repaid this
promissory note in full to its Sponsor on October 21, 2020.
Subsequent to the consummation of its initial public offering,
DCRB’s liquidity needs had been satisfied through the net proceeds
of approximately $2.0 million from the private placement held
outside of the Trust Account.
In addition to the promissory note, DCRB’s
Sponsor paid certain costs related to DCRB’s formation and
offering. Costs in the amount of $219,022 were forgiven by the
Sponsor in December 2019 and were recorded within additional
paid-in capital. As of
October 22, 2020, DCRB owed its Sponsor $135,941 for
additional offering costs, which were subsequently paid back in
November 2020.
As of October 22, 2020, the Sponsor and
WRG advanced $600,000 to DCRB to cover the purchase of additional
private placement warrants if the over-allotment were to be
exercised in full. As of October 22, 2020, advances amounting
to $600,000 were outstanding. Simultaneously with the closing of
the sale of the units from the underwriters’ partial exercise of
their over-allotment option, DCRB utilized the advance from its
Sponsor and WRG to issue an additional 514,500 private placement
warrants at a price of $1.00 per private placement
warrant.
On June 28, 2021, DCRB issued an
unsecured promissory note (the “Sponsor Note”) in the principal
amount of $1,500,000 to the Sponsor. Pursuant to the terms of the
Sponsor Note, at the Closing of the Business Combination, the
Sponsor converted $1,500,000 principal amount of the Sponsor Note
into 1,500,000 private placement warrants.
Registration Rights
The holders of the DCRB Founder Shares and
private placement warrants (and any shares of Class A Common
Stock issuable upon the exercise of the private placement warrants
and upon conversion of the DCRB Founder Shares) are entitled to
registration rights pursuant to the IPO Registration Rights
Agreement, dated October 19, 2020 (the “IPO Registration
Rights Agreement”), requiring us to register such securities for
resale (in the case of the DCRB Founder Shares, the shares of
Class A Common Stock that the DCRB Founder Shares converted
into on the Closing Date). The holders of at least $25 million
in value of these securities are entitled to demand that we file a
registration statement covering such securities and to require us
to effect up to an aggregate of three underwritten offerings of
such securities. In
Hyzon Motors 2022 Proxy
Statement | 15